Infectious Disease in Louisville, KY
11 verified infectious disease doctors in Louisville.
Infectious disease physicians diagnose and manage complex infections, including those that are chronic, resistant, or hard to identify.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. Suresh Rekhraj, MD
Infectious Disease
CMS Open Payments· $579.16 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$579.16
Total received
33
Transactions
11
Paying companies
Top paying companies
Among the 3,681 infectious disease doctors we've analyzed, about 83% received any industry payment (median $1,189 among those who did). This doctor's total is on the lower end — around the 45th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US infectious disease doctors.
Payments to Suresh Rekhraj do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Amir Piracha, MD
Infectious Disease
CMS Open Payments· $76,608 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$76,608
Total received
356
Transactions
31
Paying companies
Top paying companies
Among the 3,681 infectious disease doctors we've analyzed, about 83% received any industry payment (median $1,189 among those who did). This doctor's total is higher than 96% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US infectious disease doctors.
Payments to Amir Piracha do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Shanker Chandiramani, MD
Infectious Disease
CMS Open Payments· $3,152 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$3,152
Total received
91
Transactions
18
Paying companies
Top paying companies
Among the 3,681 infectious disease doctors we've analyzed, about 83% received any industry payment (median $1,189 among those who did). This doctor's total ranks around the 77th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US infectious disease doctors.
Payments to Shanker Chandiramani do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Vipul Panchal, MD
Infectious Disease
CMS Open Payments· $40,652 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$40,652
Total received
22
Transactions
5
Paying companies
Top paying companies
Among the 3,681 infectious disease doctors we've analyzed, about 83% received any industry payment (median $1,189 among those who did). This doctor's total is higher than 93% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US infectious disease doctors.
Payments to Vipul Panchal do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Abdolreza Agahtehrani, MD
Infectious Disease
CMS Open Payments· $225.18 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$225.18
Total received
14
Transactions
4
Paying companies
Top paying companies
Among the 3,681 infectious disease doctors we've analyzed, about 83% received any industry payment (median $1,189 among those who did). This doctor's total is on the lower end — around the 32th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US infectious disease doctors.
Payments to Abdolreza Agahtehrani do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Jacob Nunamaker, MD
Infectious Disease
CMS Open Payments· $358.47 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$358.47
Total received
15
Transactions
3
Paying companies
Top paying companies
Among the 3,681 infectious disease doctors we've analyzed, about 83% received any industry payment (median $1,189 among those who did). This doctor's total is on the lower end — around the 37th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US infectious disease doctors.
Payments to Jacob Nunamaker do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Prafull Raheja, MD
Infectious Disease
CMS Open Payments· $13,063 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$13,063
Total received
105
Transactions
23
Paying companies
Top paying companies
Among the 3,681 infectious disease doctors we've analyzed, about 83% received any industry payment (median $1,189 among those who did). This doctor's total ranks around the 88th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US infectious disease doctors.
Payments to Prafull Raheja do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Brian Kaebnick, MD
Infectious Disease
CMS Open Payments· $24,279 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$24,279
Total received
64
Transactions
9
Paying companies
Top paying companies
Among the 3,681 infectious disease doctors we've analyzed, about 83% received any industry payment (median $1,189 among those who did). This doctor's total is higher than 91% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US infectious disease doctors.
Payments to Brian Kaebnick do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Ivan Pena, MD
Infectious Disease
CMS Open Payments· $8,098 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$8,098
Total received
99
Transactions
17
Paying companies
Top paying companies
Among the 3,681 infectious disease doctors we've analyzed, about 83% received any industry payment (median $1,189 among those who did). This doctor's total ranks around the 86th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US infectious disease doctors.
Payments to Ivan Pena do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Mohammad Mathbout, MD
Infectious Disease
CMS Open Payments· $4,193 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$4,193
Total received
58
Transactions
6
Paying companies
Top paying companies
Among the 3,681 infectious disease doctors we've analyzed, about 83% received any industry payment (median $1,189 among those who did). This doctor's total ranks around the 80th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US infectious disease doctors.
Payments to Mohammad Mathbout do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Mohammad Zmaili, MD
Infectious Disease
CMS Open Payments· $276.12 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$276.12
Total received
3
Transactions
1
Paying companies
Top paying companies
Among the 3,681 infectious disease doctors we've analyzed, about 83% received any industry payment (median $1,189 among those who did). This doctor's total is on the lower end — around the 34th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US infectious disease doctors.
Payments to Mohammad Zmaili do not imply any wrongdoing. Many are meals, education, or research support.